ArticleRheumatology and therapy2022

Population Pharmacokinetics and Exposure-Response Analyses for Risankizumab in Patients with Active Psoriatic Arthritis.

Neha Thakre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.